TGFBR2 and neoplasm: We have previously shown that TGFβ signaling and TGFβ receptor type‐2 (TGFBR2) seem to have a tumor promoting role in human estrogen receptor (ER)‐negative breast cancer (Keklikoglou et al., 2012).